Real Patients, Real Stories – Hear from an Emory Liver Transplant Patient

Simone Whitehead was an active 30-year-old, running half marathons and chasing around her 2-year-old son. In April 2016, she began to feel ill, and she slowly started getting worse. Tests revealed that her liver...

Break the Stigma: Let’s Talk About Mental Illness

The words mental illness often bring specific ideas or images to mind. But, the reality is that mental illness affects far more people than you imagine. According to the National Alliance for Mental Illness...

Emory Leads Research on FDA-Approved Drug in HIV Positive Patients Receiving Kidney Transplants

Emory Transplant Center will soon begin enrolling patients into a new clinical trial that will test an FDA-approved drug in HIV positive patients receiving a kidney transplant. The research study will evaluate the safety...

Aortic Stenosis

The aortic valve is tremendously important, controlling blood flow from the heart to the rest of the body. In aortic stenosis, the valve does not open fully, restricting blood flow from the heart. In...

Emory Transplant Center Awarded Grant to Reduce Disparities in Access to Transplant

The National Institutes of Minority Health and Health Disparities has awarded $2.6 million over five years to the Emory Transplant Center and six other transplant centers and organizations in the Southeastern Kidney Transplant Coalition....

Improving Survival Rates for Liver Cancer Patients

Emory is nationally renowned for using a multidisciplinary approach to treat cancer. But many may not know there is a multidisciplinary team right here at the Emory Transplant Center with the mission of improving...

Belatacept Provides Better Kidney Survival Rates than Current Standard of Care

A study of kidney transplant recipients has shown for the first time that the drug belatacept (Nulojix), which controls the immune system and prevents graft rejection, has a better record of patient and organ...

Finding a Better Antifungal Agent for Lung Transplant Patients

Because human airways are open to airborne fungal spores and pathogens, lung transplant patients are especially susceptible to infections, a major cause of post-transplant disease and even death. A reliable means of preventing fungal...